Sort
82,697 grants matching “vaccine development”
Vermont Immunobioloigy/ Infectious Diseases Center
$2,159,470Ralph C. Budd · University Of Vermont & St Agric College · P20 · FY2014 · GM
Center for Population Health Research
$2,159,403Curtis William Noonan · University Of Montana · P20 · FY2022 · GM
Center for Population Health Research
$2,159,403Curtis William Noonan · University Of Montana · P20 · FY2024 · GM
Center for Population Health Research
$2,159,403Curtis William Noonan · University Of Montana · P20 · FY2021 · GM
Center for Population Health Research
$2,159,403Curtis William Noonan · University Of Montana · P20 · FY2023 · GM
Pathogenic Determinants of Monkeypox Virus and Other Orthopox Viruses
$2,159,196Peter Jahrling · Niaid Extramural Activities · Z01 · FY2007 · AI
LIVE ATTENUATED MULTIPLY DELETED HIV1 VACCINE FOR AIDS
$2,158,944Harvard University (Medical School) · P01 · FY2001 · AI
Units for HIV/AIDS Clinical Trials Networks
$2,158,520Michael C Keefer · University Of Rochester · UM1 · FY2012 · AI
Yellow Fever, rDNA (EP+IL-12) and rAd35 as Vectors for AIDS Vaccine Development
$2,158,371David I Watkins · University Of Miami School Of Medicine · P01 · FY2012 · AI
Mayo Clinic SPORE in Pancreatic Cancer
$2,157,728Gloria M. Petersen · Mayo Clinic Rochester · P50 · FY2016 · CA
Innovative Strategies to Combat Antibiotic-resistant Infections
$2,156,770Scott J Hultgren · Washington University · U19 · FY2021 · AI
DCP- Cancer Immunoprevention Laboratory Support
$2,156,353Lynn Briscoe · Leidos Biomedical Research, Inc. · N01 · FY2025 · CA
An oral vaccine against Chlamydia trachomatis
$2,156,302Guangming Zhong · University Of Texas Hlth Science Center · U01 · FY2025 · AI
Drug Repurposing Screening for Rare and Neglected Diseases
$2,156,297Wei Zheng · National Center For Advancing Translational Sciences · ZIA · FY2021 · TR
Dana Farber/Harvard Cancer Center Ovarian Cancer SPORE grant
$2,156,021Alan David D'andrea · Dana-Farber Cancer Inst · P50 · FY2022 · CA
Nonhuman Primate Reagent Resource
$2,155,998Diogo Magnani · Univ Of Massachusetts Med Sch Worcester · U24 · FY2019 · AI
NONHUMAN PRIMATE CORE HUMORAL IMMUNOLOGY LAB AIDS VACCINE R&D
$2,155,958David C Montefiori · Duke University · N01 · FY2013 · AI
University of Miami Pediatric Perinatal HIV/AIDS Clinical Trails Unit
$2,155,675Gwendolyn B. Scott · University Of Miami School Of Medicine · UM1 · FY2012 · AI
Specialized Program of Research Excellence
$2,155,519Robert L Ferris · University Of Pittsburgh At Pittsburgh · P50 · FY2014 · CA
HIV VACCINES TRIAL UNITS
$2,155,503Fred Hutchinson Cancer Research Center · U01 · FY2005 · AI
CPRC Resources
$2,155,294Melween I. Martinez · University Of Puerto Rico Med Sciences · P40 · FY2023 · OD
CPRC Resources
$2,155,134Melween I. Martinez · University Of Puerto Rico Med Sciences · P40 · FY2022 · OD
Clinical Development of Chimp Adenovirus Vectors
$2,155,092Hildegund C. J. Ertl · Wistar Institute · U19 · FY2012 · AI
HIV-1 Vaccine Based on Chimp Serotypes of Adenovirus
$2,155,092Hildegund C. J. Ertl · Wistar Institute · U19 · FY2012 · AI
The Gonorrhea Vaccine Cooperative Research Center
$2,154,189Ann E. Jerse · Henry M. Jackson Fdn For The Adv Mil/Med · U19 · FY2020 · AI